NO20021441D0 - Antistoff-fargekonjugater for binding til målstrukturer av angiogenese for intraoperativt å avbilde tumorperiferier - Google Patents

Antistoff-fargekonjugater for binding til målstrukturer av angiogenese for intraoperativt å avbilde tumorperiferier

Info

Publication number
NO20021441D0
NO20021441D0 NO20021441A NO20021441A NO20021441D0 NO 20021441 D0 NO20021441 D0 NO 20021441D0 NO 20021441 A NO20021441 A NO 20021441A NO 20021441 A NO20021441 A NO 20021441A NO 20021441 D0 NO20021441 D0 NO 20021441D0
Authority
NO
Norway
Prior art keywords
intraoperatively
angiogenesis
binding
target structures
dye conjugates
Prior art date
Application number
NO20021441A
Other languages
English (en)
Other versions
NO20021441L (no
Inventor
Michael Schirner
Kai Licha
Ludger Dinkelborg
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7924318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021441(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20021441D0 publication Critical patent/NO20021441D0/no
Publication of NO20021441L publication Critical patent/NO20021441L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20021441A 1999-09-24 2002-03-22 Antistoff-fargestoffkonjugater mot angiogenesemålstrukturer for intraoperativ presentasjon av tumorperiferier NO20021441L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947559A DE19947559A1 (de) 1999-09-24 1999-09-24 Antikörper-Farbstoffkonjugate gegen Zielstrukturen der Angiogenese zur intraoperativen Tumorranddarstellung
PCT/EP2000/008121 WO2001023005A1 (de) 1999-09-24 2000-08-19 Antikörper-farbstoffkonjugate gegen zielstrukturen der angiogenese zur intraoperativen tumorranddarstellung

Publications (2)

Publication Number Publication Date
NO20021441D0 true NO20021441D0 (no) 2002-03-22
NO20021441L NO20021441L (no) 2002-05-15

Family

ID=7924318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021441A NO20021441L (no) 1999-09-24 2002-03-22 Antistoff-fargestoffkonjugater mot angiogenesemålstrukturer for intraoperativ presentasjon av tumorperiferier

Country Status (23)

Country Link
EP (2) EP1214099A1 (no)
JP (1) JP2003510294A (no)
KR (2) KR100832937B1 (no)
CN (1) CN1269530C (no)
AU (1) AU779026B2 (no)
BG (1) BG65682B1 (no)
BR (1) BR0014192A (no)
CA (1) CA2385593A1 (no)
CZ (1) CZ2002991A3 (no)
DE (1) DE19947559A1 (no)
EE (1) EE05176B1 (no)
HK (1) HK1050491A1 (no)
HU (1) HUP0202625A2 (no)
IL (2) IL148405A0 (no)
MX (1) MXPA02002639A (no)
NO (1) NO20021441L (no)
NZ (1) NZ517944A (no)
RO (1) RO121598B1 (no)
RU (1) RU2002109237A (no)
SK (1) SK3972002A3 (no)
WO (1) WO2001023005A1 (no)
YU (1) YU20702A (no)
ZA (1) ZA200203225B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062800A1 (en) 2000-02-24 2001-08-30 Eidgenössische Technische Hochschule Zürich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
AT413487B (de) * 2002-08-12 2006-03-15 Igeneon Krebs Immuntherapie Verwendung von antikörpern gegen ein tumor-assoziiertes antigen
NO20034351D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av endometrose
EP1816475A1 (en) * 2004-07-22 2007-08-08 Bayer Schering Pharma Aktiengesellschaft Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
EP2422187A4 (en) * 2009-04-21 2013-01-02 Univ Utah Res Found LIGHT EMITTING COLOR FOR PEROPERATIVE IMAGING OR BIOPSY OF THE SENTINEL GANGLION
EP3493855A4 (en) * 2016-08-02 2020-04-01 ISI Life Sciences, Inc. METHOD FOR DETECTION OF CANCER CELLS.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
ATE198712T1 (de) * 1994-07-11 2001-02-15 Univ Texas Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen
TWI259837B (en) * 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis

Also Published As

Publication number Publication date
BG65682B1 (bg) 2009-06-30
EP1532988A2 (de) 2005-05-25
WO2001023005A1 (de) 2001-04-05
EP1532988A3 (de) 2008-09-17
HK1050491A1 (en) 2003-06-27
BG106528A (bg) 2002-12-29
CN1269530C (zh) 2006-08-16
EE200200152A (et) 2003-04-15
NO20021441L (no) 2002-05-15
EE05176B1 (et) 2009-06-15
DE19947559A1 (de) 2001-04-19
NZ517944A (en) 2004-06-25
AU6702600A (en) 2001-04-30
YU20702A (sh) 2005-06-10
CZ2002991A3 (cs) 2002-06-12
ZA200203225B (en) 2003-07-23
JP2003510294A (ja) 2003-03-18
KR100832937B1 (ko) 2008-05-27
BR0014192A (pt) 2002-05-21
AU779026B2 (en) 2005-01-06
RU2002109237A (ru) 2003-11-27
KR20020039349A (ko) 2002-05-25
IL148405A0 (en) 2002-09-12
CA2385593A1 (en) 2001-04-05
SK3972002A3 (en) 2002-09-10
HUP0202625A2 (en) 2002-12-28
PL354027A1 (en) 2003-12-15
CN1376074A (zh) 2002-10-23
RO121598B1 (ro) 2007-12-28
EP1214099A1 (de) 2002-06-19
IL148405A (en) 2009-06-15
MXPA02002639A (es) 2002-07-30
KR20070087232A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
NO20021441D0 (no) Antistoff-fargekonjugater for binding til målstrukturer av angiogenese for intraoperativt å avbilde tumorperiferier
IS6375A (is) Lyfjagjöf til öftrunar á blöðruhálskrabbameini
NO20022681D0 (no) Kontinuerlig fremstilling av silicabaserte mikrogeler
DE69727908D1 (de) Tumor-Nekrosis-Faktor verwandter Receptor, TR6
IS6765A (is) Arýl eða heteróarýl samtengd imídasól efnasamböndsem bólgueyðandi og kvalastillandi miðlar
NO20025792L (no) Kinazolinderivater for behandling av tumorer
IS2468B (is) Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini
AU3041100A (en) Binding of antibody fragments to solid supports
ATE326470T1 (de) Neue aza-indolyl derivate
ID29223A (id) Selaput baru atau bahan pengikat untuk mengontrol penyerapan obat
MA25850A1 (fr) Conjugues de pro-parfums photolabiles.
DK1237584T3 (da) Receptorbindende konjugater
NO20014105D0 (no) Texanderivater for malrettet kreftterapi
NO20014607L (no) Sammensetninger til forbedring av fertilitet
NO20011674D0 (no) Stropplös tålås-binding for snowboards
NO20015828D0 (no) Fremgangsmåter for fremstilling av 5'-nukleinsyre- proteinkonjugater
DK0942754T3 (da) Konjugater anvendelige til behandlingen af prostatacancer
NO20015227D0 (no) Fremgangsmåte for å öke effektiviteten til anti-cancer midler
ATE434619T1 (de) Thienodibenzazulenverbindungen als tumornekrosefaktorhemmer
IS5502A (is) Samtengd efnasambönd nytsamleg við meðhöndlun á krabbameini í blöðruhálskirtli
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
EE200200473A (et) Uudne jämesoolevähi-spetsiifiline antikeha
NO20005322L (no) Fremgangsmåte for å öke effektiviteten av handel
WO2001028593A3 (en) Conjugates useful in the treatment of prostate cancer
PT1030319E (pt) Nucleo toroidal